Skip To Main Content
Sort by

Filtera

Återställ
  • Filtera
Patient Support: How to Manage a Serious Illness?

Patient Support: How to Manage a Serious Illness

At Sanofi, our passion is to prevent, treat, and cure diseases. We are driven by the desire to improve public health and find new solutions for patients by combining science with a deep understanding of patient needs.

IMROZ Study - Isa-VRd for patients with NDMM-TI

IMROZ Study - Isa-VRd for patients with NDMM-TI

BRIGHT publication

BRIGHT publication

Polyp Gossip

Polyp Gossip Overview

Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences. Each episode features esteemed guests, including experts and patients, offering valuable insights into the evolving world of CRSwNP.

The Hematology Podcast - Season 5

The Hematology Podcast - Season 5

Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders.

Interview with Dr. Pereira: Chronic Itch in AD and PN

Interview with Dr. Pereira: Chronic Itch in AD and PN

Itch and Pain in Atopic Dermatitis and Prurigo Nodularis – Clinical Challenges in Achieving Disease Control

Itch and Pain in Atopic Dermatitis and Prurigo Nodularis – Clinical Challenges in Achieving Disease Control

Prevent the 1<sup>st</sup> event Forum

Prevent the 1st event Forum

Lunch & Learn Webinar #2 - Biomarkers in Lysosomal Storage Diseases

Lunch & Learn Webinar #2 - Biomarkers in Lysosomal Storage Diseases

Om BALANS i Region Göteborg

Om BALANS i Region Göteborg

The Deliver-G study

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1

The RESTORE-G Real World Evidence Study

The RESTORE-G Real World Evidence Study

RESTORE-G: Real-world analysis in insulin-naïve adults with T2D on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†2